Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy. - Wikidata - awgldk - TriplyDB

Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.

Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.

http://www.wikidata.org/entity/Q53908857

about

Growth factors for treating diabetic foot ulcers Management of diabetic foot: Brief synopsis for busy orthopedist The Use of Biologic Scaffolds in the Treatment of Chronic Nonhealing Wounds Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial Lacritin-mediated regeneration of the corneal epithelia by protein polymer nanoparticles Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers Biologics in dermatologic therapy - an update.Diagnosis and treatment of diabetic foot infections.Becaplermin gel in the treatment of diabetic neuropathic foot ulcers Foot ulcers in the diabetic patient, prevention and treatment.Role for heat shock protein 90α in the proliferation and migration of HaCaT cells and in the deep second-degree burn wound healing in mice.Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor Multivalent Conjugates of Sonic Hedgehog Accelerate Diabetic Wound Healing.Diabetic foot complications: diagnosis and management.Evaluation of recombinant human platelet-derived growth factor as an agent for wound bed preparation in traumatic wounds.Calreticulin enhances porcine wound repair by diverse biological effects.Modeling the effects of treating diabetic wounds with engineered skin substitutes.Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats.Platelet-rich plasma: support for its use in wound healing.Innovative approaches in wound healing: trajectory and advances.Updating on understanding and managing chronic wound.Biological therapies for the treatment of cutaneous wounds: phase III and launched therapies.Growth factor conjugation: strategies and applications.Electrospun 3D Fibrous Scaffolds for Chronic Wound Repair Diabetes and Wound Angiogenesis.Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells.Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.Management of diabetic foot ulcers with a TLC-NOSF wound dressing.Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.Comparison of human umbilical cord blood-derived mesenchymal stem cells with healthy fibroblasts on wound-healing activity of diabetic fibroblasts.

P2860

Q24186333-67057A84-F536-425E-AAB5-F4ADC9540AA5 Q26778546-DA0B3A97-6F4B-494A-91D7-105B47802DEC Q26798450-3A30F3C4-2523-41DC-B861-A01D7BF055F0 Q27302994-CB7957B4-93CF-44E4-80CF-58862486B2EB Q28118688-7CDC0687-E3BF-4BC7-8C0E-7A94D4355393 Q28201897-9D56584B-D046-4ADD-BB6C-6936A06AE305 Q33607620-71F2BF11-2B71-4B59-9040-A4C09853648E Q34357233-3826E939-1E04-4A86-B50A-B8973072948B Q34595282-6489024E-7164-4A23-B52F-FEBADCC686A6 Q34640126-FD76D4DC-42F0-4393-B698-6E1BE8C855C9 Q35222831-D4337CAF-3EAC-4E22-A273-7B30DAD732B3 Q35967028-CB5D6B04-AA90-428E-B0E9-46BDEC9879BC Q36011804-3BD6C8FB-308D-4B69-A36A-B6FD3607DCE2 Q36229289-9AEF1287-268D-4295-B34C-CD831BDFF17C Q36391074-E2CC7F70-FA91-4F9E-B518-FC5510213B04 Q36855654-0F1E7A13-5672-4E4B-859A-D98BB285FBDA Q36890596-8E2AC0D7-33CC-4273-89B2-2DEEAE47D0A8 Q37367824-DCA505E9-806B-4C16-BA58-2EACC614888C Q37721175-C3973F49-A8FC-4775-84DB-AE0ADB0BC9D0 Q38073801-0E309928-35CC-40E8-8193-A6E5657D0E71 Q38112477-0B8AE489-8FF3-449A-99E7-AA436191BC36 Q38149224-17CD9D7E-8739-41CA-9B7F-6AC7B45369FB Q38204731-6C309FBF-C3F5-40EE-A688-F7932E6A61BE Q38643315-3C75F82E-8376-4548-B534-BE3FE7E3761C Q39411007-7801451B-4B18-4BB0-A9F9-C5D1799FF58E Q40157980-D971B2C9-25A1-498E-888C-FAA4574ADDB6 Q41893958-B6B6439E-7EC1-48A6-A07A-9CBC4C03C31B Q42639200-02F05B43-3E56-46FF-82E7-4E56154A50F7 Q43242639-BD8A62E8-5349-4A9C-BA25-21D21FB856B0 Q50113367-02DD3524-4C49-48D4-AC17-195DB109250F

P2860

Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.

http://www.wikidata.org/entity/Q53908857

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Recombinant human platelet-der ...... inical evaluation of efficacy.

@en

Recombinant human platelet-derived growth factor-BB

@nl

type

label

Recombinant human platelet-der ...... inical evaluation of efficacy.

@en

Recombinant human platelet-derived growth factor-BB

@nl

prefLabel

Recombinant human platelet-der ...... inical evaluation of efficacy.

@en

Recombinant human platelet-derived growth factor-BB

@nl

P1433

Q53908857-8692A42D-6328-47F1-9D21-7AF34917E44D

P1476

Q53908857-3641B4D2-2E89-4BE4-AB8F-9CFAB5CEFF63

P2093

Q53908857-0FF9871B-1E6C-4223-AB39-8A7BFACAEF8D

Q53908857-6441CA05-DC0B-42BA-9B5D-1965E66101DB

Q53908857-6D66F917-F8E1-47BA-B95B-56479EEEA6DE

Q53908857-7D9BBC8E-11B4-4982-85FC-4B2A422B5DCB

Q53908857-88E9418A-C12D-482B-9B7D-91A75138744E

Q53908857-9F039330-1589-49E7-A4F9-2B5011267ACC

Q53908857-E8FC416C-1D9F-4BEE-ACE4-FF924D3748DC

P2860

Q53908857-032BDE1E-C060-4704-8C3B-E19AE04DFD4D

Q53908857-103ABE2C-0775-486E-846B-9DB2EF1FC68B

Q53908857-10814E7B-25C5-42A6-8062-745E7A55B175

Q53908857-119F4913-6029-467A-9A1B-5A391A9EBA1D

Q53908857-49299BFD-49BD-4CE1-B7AF-853BF7B96A92

Q53908857-58334800-157D-42D3-A4C8-7A4E75376D8B

Q53908857-715D1420-098B-4721-88D3-2697BB9925E1

Q53908857-A7616392-718E-47AB-AA0C-76FFF42049A9

Q53908857-B7992726-84A1-4ACA-87BB-61275E22DAFC

Q53908857-BB4677DB-B776-4243-B77D-1C2902494A7D

P304

Q53908857-1B428068-2BAB-4C89-894E-70C0529AECD4

P31

Q53908857-81701FEF-1688-4B90-8AA3-435DD0120480

P356

Q53908857-9A3E52E3-78AB-4649-8BC5-2749206E2463

P433

Q53908857-7E265420-AB77-481D-848B-9AB0441AD785

P478

Q53908857-6AFE7FE9-5A2D-4F86-814F-6D2B6F0665FD

P577

Q53908857-28913F53-590F-4DFC-9DA2-69FFCADE9D5F

P698

Q53908857-39DCA43C-1825-496C-A987-D3B7A6B18574

P356

J.1524-475X.2000.00162.X

P1433

Wound Repair and Regeneration

P1476

Recombinant human platelet-der ...... inical evaluation of efficacy.

@en

P2093

B Wong

http://www.w3.org/2001/XMLSchema#string

C Y Lau

http://www.w3.org/2001/XMLSchema#string

G Sibbald

http://www.w3.org/2001/XMLSchema#string

J M Embil

http://www.w3.org/2001/XMLSchema#string

J M Smiell

http://www.w3.org/2001/XMLSchema#string

J Tousignant

http://www.w3.org/2001/XMLSchema#string

K Papp

http://www.w3.org/2001/XMLSchema#string

P2860

Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.

Role of platelet-derived growth factor in wound healing.

Growth factors and wound healing: Part II. Role in normal and chronic wound healing.

Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.

Epidermal cytokines and their roles in cutaneous wound healing.

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

The role of growth factors in wound healing.

Therapeutic footwear for patients with diabetes.

The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes.

P304

162-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1524-475X.2000.00162.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10886806

http://www.w3.org/2001/XMLSchema#string